RIVAXA 20mg Tablet is categorized as an anticoagulant, commonly referred to as a blood thinner. Its primary function is to prevent and manage blood clot formation, which is crucial in decreasing the likelihood of serious conditions such as strokes and heart attacks. This medication is particularly beneficial for preventing and treating clotting issues in various areas of the body, including the veins in the legs, lungs, brain, and heart. It is often prescribed to individuals with atrial fibrillation, a condition characterized by irregular heart rhythms, to avert the risk of clot development. Additionally, RIVAXA 20mg is indicated for patients who have undergone knee or hip replacement surgeries, as it helps mitigate the risk of clot formation in these situations. The tablet can be taken regardless of meals but should ideally be consumed at the same time every day to maximize its effectiveness. In some cases, patients may need to continue taking this medication for extended periods, potentially even for their entire lives. It is critical not to discontinue use or alter the dosage without consulting a healthcare professional, as doing so may elevate the risk of serious cardiovascular events. To further decrease the likelihood of clots, patients are encouraged to adopt healthy lifestyle practices, which include avoiding smoking, maintaining a balanced diet, engaging in regular physical activities, and managing body weight. The most frequently reported side effect of RIVAXA 20mg Tablet is an increased tendency to bleed more readily than usual, manifesting as nosebleeds or unexplained bruising. If any abnormal symptoms are experienced, it is imperative to inform a healthcare provider promptly. This medication is contraindicated in individuals with severe renal or hepatic impairment, those who are actively bleeding, or those taking other anticoagulant medications. It is also advised against breastfeeding while on RIVAXA.
-15%

RIVAXA 20
Original price was: ₹505.30.₹431.18Current price is: ₹431.18.
Reviews
There are no reviews yet.